$SNPS

Why is Synopsys stock tumbling today? By Investing.com

Investing.com reports Synopsys (SNPS) shares fell 9.5% to $377.42, near a 52-week low, after Chinese AI startup Moonshot AI said its Kimi K3 completed a full chip design flow in 48 hours using open-source EDA tools. The stock also faced pressure after Synopsys planned to phase out some process control software, Reuters reported. Cadence also dropped.

Original reporting
Published Jul 17, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 6:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$SNPS
Bearish
high confidence
Mentioned
$SNPS
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SNPSBearishMed
01

Why it matters

If customers accelerate away from proprietary EDA for parts of the flow, Synopsys could face both near-term revenue pressure and longer-term competitive share risk, especially if the market extrapolates the demo broadly.

02

Market read

The article provides a same-day catalyst narrative for SNPS, linking open-source EDA progress and Synopsys’ product discontinuation to a large intraday drawdown.

03

What to watch

The article references a July 7 Reuters report and a same-day demo, but does not quantify revenue exposure of the discontinued products or provide customer transition timelines, which could limit how far the selloff should extend.

Relevance 7/10Novelty 6/10Timing: intraday selloff with new catalysts cited (open-source EDA demo and July 7 product phase-out)

Background

The piece frames Synopsys’ decline around two themes: an open-source EDA workflow demonstration and Synopsys’ plan to phase out certain manufacturing process control software.

Company-level read

Ticker impact

$SNPSBearishHigh confidence
Context

Synopsys shares fell 9.5% after Moonshot AI showed a full chip design flow using open-source EDA tools that bypass Synopsys software.

Expected impact

Bearish bias with elevated volatility until customers and guidance clarify the revenue impact of the software discontinuation.

Evidence & confidence

The article cites two direct, company-specific catalysts: a sector read-across threat from open-source EDA and Synopsys’ intent to phase out specific product lines, both tied to the same-day selloff.

Market effects

Market treats open-source EDA as a threat to proprietary toolchains, pressuring EDA peers and potentially compressing valuation multiples.

US-listed EDA names sold alongside broader US tech weakness; no direct regional-specific catalyst beyond sentiment.

Mentions major global chipmakers (Samsung, SK Hynix, Kioxia) as affected by Synopsys’ software phase-out, implying worldwide customer impact.

Counterpoint

The open-source demo may not translate into scalable, production-grade adoption, and Synopsys’ shift toward higher-margin AI design tools could offset near-term disruption.

Key entities

  • Synopsys

    EDA software provider whose stock dropped sharply amid open-source EDA threat and planned phase-out of process-control products.

  • Moonshot AI

    Chinese AI startup whose Kimi K3 demo is cited as autonomously completing a chip design flow using open-source EDA tools.

  • Cadence Design Systems

    EDA rival mentioned as also falling on the same news, reinforcing sector-wide read-across.

  • Samsung Electronics

    Named among major chipmakers notified by Synopsys about phasing out certain process control software products.

  • SK Hynix

    Named among major chipmakers notified by Synopsys about phasing out certain process control software products.

Related articles

$SNPSMedAI 8/10

Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary.

Synopsys raised its full-year fiscal 2026 revenue guidance midpoint to $9.665 billion and lifted non-GAAP EPS guidance to $14.76 at the midpoint, driven by strong first-half performance, accelerating Ansys integration synergies, and expanded operating margins. For Q3 fiscal 2026, management guided revenue of $2.41–$2.46 billion and non-GAAP EPS of $3.63–$3.69.

$SNPSMed

Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed

Synopsys' valuation remains difficult to assess on its headline numbers. The forward GAAP price-to-earnings (P/E) makes it look extraordinarily expensive, while the price-to-sales (P/S) ratio does the opposite. The reason is the $35 billion Ansys acquisition. The forward P/E of 138.39x sits 91% above its 5-year average of 72.47x. The Ansys acquisition is holding down the reported earnings, making the stock look inflated.

$SNPSMed

Synopsys Doubles Down on AI Chip Design With Microsoft and AMD. How to Play SNPS Stock Here.

Synopsys (SNPS) shares rose more than 4% after the company unveiled autonomous AI workflows for chip design at the 2026 DAC Chips to Systems Conference. Synopsys said the workflows, built with Microsoft (MSFT) and evaluated by AMD (AMD), can cut debug cycles by 25% to 40%. SNPS reported fiscal Q2 2026 revenue of $2.27B and raised FY2026 outlook to about $9.665B revenue and $14.76 EPS.

$SNPSMed

Synopsys Certifies Its Chip Design Tools on Intel’s 14A Node

Synopsys said it certified its chip design toolchain for Intel’s (INTC) 14A process node, announced July 27, 2026. The certification covers digital and analog implementation, signoff, multiphysics analysis, and node-tuned interface and foundation IP, plus updates to its 3DIC Compiler for Intel packaging. Intel reported 14A foundry revenue not broken out, with $5.8B foundry revenue and a $2.09B operating loss in Q2 2026.